A phase III clinical trial of alpha, beta-arteether injection 150 mg/ml in patients of P falciparum malaria.

Authors:
Address: Lincoln Pharmaceuticals Ltd, Khatraj 382721.
Journal:

Publication:

abstract

The aim of study was to evaluate efficacy and safety of alpha, beta-arteether injection 150 mg/ml by performing a phase III, multicentre, open label, and single treatment study in patients with P falciparum malaria. A total of 145 patients with P falciparum malaria were screened to achieve patient pool of 101 subjects based on inclusion and exclusion criteria, from which 100 patients completed the study successfully. Mean cure rate was calculated as primary efficacy parameter, while mean parasite clearance time (hours) and mean fever clearance time (hours) were calculated as secondary efficacy parameters, to evaluate efficacy of alpha, beta-arteether injection 150 mg/ml. Safety evaluation was measured by observing and monitoring adverse events, clinical examination, assessment of vitals and haematology laboratory parameters. Statistical analysis was performed with 5% level of significance. Mean cure rate, mean parasite clearance time (hours) and mean fever clearance time (hours) were 99.01%, 24.72 +/- 0.41 hours and 46.86 +/- 0.97 hours respectively. A total of 6 patients were observed with pain at injection site out of 101 enrolled patients. There were no clinically significant vitals and haematology changes. There were no abnormal posttreatment values observed. The study confirmed that alpha, gamma-arteether injection 150 mg/ml is highly effective in treatment of P falciparum malaria.

Related Articles
Efficacy and safety of beta-arteether and alpha/beta-arteether for treatment of acute Plasmodium falciparum malaria.
Am J Trop Med Hyg. 2006
Efficacy and safety of beta-arteether and alpha/beta-arteether for treatment of acute Plasmodium falciparum malaria.
Pareek A, Nandy A, Kochar D, Patel KH, Mishra SK, Mathur PC. Am J Trop Med Hyg. 2006 Jul; 75(1):139-42.
Multicentric clinical trials for safety and efficacy evaluation of alpha;beta arteether in complicated P. falciparum malaria.
J Assoc Physicians India. 2001
Multicentric clinical trials for safety and efficacy evaluation of alpha;beta arteether in complicated P. falciparum malaria.
Asthana OP, Srivastava JS, Pandey TK, Vishwanathan KA, Dev V, Mahapatra KM, Nayak NC, Balsara AB, Mandal OP, Gupta N, et al. J Assoc Physicians India. 2001 Dec; 49:1155-60.
A multicentric study with arteether in patients of uncomplicated falciparum malaria.
J Assoc Physicians India. 2001
A multicentric study with arteether in patients of uncomplicated falciparum malaria.
Asthana OP, Srivastava JS, Kamboj VP, Valecha N, Sharma VP, Gupta S, Pande TK, Vishwanathan KA, Mahapatra KM, Nayak NC, et al. J Assoc Physicians India. 2001 Jul; 49:692-6.
Efficacy of arteether in chloroquine resistant falciparum malaria in eastern India.
Indian J Med Res. 2004
Efficacy of arteether in chloroquine resistant falciparum malaria in eastern India.
Mandal PK, Sarkar N, Pal A. Indian J Med Res. 2004 Jan; 119(1):28-32.
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.
Br J Clin Pharmacol. 2002
Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.
Looareesuwan S, Oosterhuis B, Schilizzi BM, Sollie FA, Wilairatana P, Krudsood S, Lugt ChB, Peeters PA, Peggins JO. Br J Clin Pharmacol. 2002 May; 53(5):492-500.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.